October 17, 2023
Anti-abortion activists are telling the U.S. Supreme Court that if the justices review parts of a Fifth Circuit ruling reinstating the approval of an abortion medication, they should consider the entire case.
October 13, 2023
Politicians, doctors, legal professors and pharmaceutical companies have turned out en masse to urge the U.S. Supreme Court to review a Fifth Circuit panel's decision that would significantly curb access to the abortion medication mifepristone nationwide, attacking the ruling as deeply flawed and warning of its potentially seismic effects beyond abortion access.
September 08, 2023
The U.S. Department of Justice and a distributor of the abortion medication mifepristone urged the U.S. Supreme Court on Friday to review a Fifth Circuit decision that threatens to curb access to the drug, marking the latest chapter in the national battle over abortion access following Roe v. Wade's reversal.